135 related articles for article (PubMed ID: 35264066)
1. Calreticulin (CALR)-induced activation of NF-ĸB signaling pathway boosts lung cancer cell proliferation.
Gao F; Mu X; Wu H; Chen L; Liu J; Zhao Y
Bioengineered; 2022 Mar; 13(3):6856-6865. PubMed ID: 35264066
[TBL] [Abstract][Full Text] [Related]
2. Calcium-activated nucleotides 1 (CANT1)-driven nuclear factor-k-gene binding (NF-ĸB) signaling pathway facilitates the lung cancer progression.
Gao F; Hu X; Liu W; Wu H; Mu Y; Zhao Y
Bioengineered; 2022 Feb; 13(2):3183-3193. PubMed ID: 35068336
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells.
Liu X; Sun N; Dong Y; Li J; Liu Y; Ren Y; Yang C; Zhang L; Zhou Y; Tong Z; Ding J; Zhao X; Liu Y; He R; Xu K; Wu Y; Huang Y; Wang H; Tao X; Liu Y
Int Immunopharmacol; 2015 Apr; 25(2):416-24. PubMed ID: 25704851
[TBL] [Abstract][Full Text] [Related]
4. PMEPA1 facilitates non-small cell lung cancer progression via activating the JNK signaling pathway.
Tan B; Chen Y; Xia L; Yu X; Peng Y; Zhang X; Yang Z
Cancer Biomark; 2021; 31(3):203-210. PubMed ID: 33896822
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Significance of Keap1 mRNA Expression for Lung Cancer Based on Microarray and Clinical Information from Oncomine Database.
Liu GY; Zhang W; Chen XC; Wu WJ; Wan SQ
Curr Med Sci; 2021 Jun; 41(3):597-609. PubMed ID: 34169426
[TBL] [Abstract][Full Text] [Related]
6. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
8. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
9. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
10. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
11. NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway.
Liu X; Liu X; Zhuo C; Shen J; Lu K; Sha M; Ye J; Huang J; Han H; Yu H
Discov Med; 2023 Dec; 35(179):936-945. PubMed ID: 38058058
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
15. Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma.
Ren S; Wang J; Xu A; Bao J; Cho WC; Zhu J; Shen J
Cell Oncol (Dordr); 2022 Feb; 45(1):57-67. PubMed ID: 35025009
[TBL] [Abstract][Full Text] [Related]
16. IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUAD.
Wu C; Li X; Zhang D; Xu B; Hu W; Zheng X; Zhu D; Zhou Q; Jiang J; Wu C
Cell Physiol Biochem; 2018; 48(6):2493-2502. PubMed ID: 30121641
[TBL] [Abstract][Full Text] [Related]
17. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
18. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
19. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
20. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]